1000 Genentech, Inc.
The Portfolio Strategy and Planning team serves as a strategic partner within Genentech’s Research and Early Development (gRED) organization, shaping R&D priorities and advancing innovative therapeutics. This role spans early research through Phase II across multiple therapeutic areas, collaborating with senior leaders to inform strategic decisions and guide portfolio investments. The position sits at the intersection of science, strategy, and business to influence R&D direction and accelerate the development of transformative medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for 1000 Genentech, Inc..
26% above the average for this role
R&D Portfolio & PMO Manager
Innovation Concrete Laboratory
Innovation Portfolio Lead
Corteva Agriscience
pRED Portfolio Strategy & Delivery Lead
Roche
Research & Development Field Account Manager Strategic Accounts
Sartorius
Director, Disease Area Strategy Lead
Amgen
Director, Portfolio Strategy - Global Initiatives
Flagship Pioneering, Inc.